SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001929354-23-000017
Filing Date
2023-06-29
Accepted
2023-06-29 08:22:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 g13.txt SC 13G/A 6365
  Complete submission text file 0001929354-23-000017.txt   8006
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Subject) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89290 | Film No.: 231054378
SIC: 2834 Pharmaceutical Preparations

Mailing Address PALM GROVE HOUSE WICKHAMS CAY 1 ROAD TOWN TORTOLA D8 VG1110
Business Address PALM GROVE HOUSE WICKHAMS CAY 1 ROAD TOWN TORTOLA D8 VG1110 00377 99 90 25 95
Caissa Capital Management ltd. (Filed by) CIK: 0001929354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G/A